🇺🇸 FDA
Patent

US 8563035

Oral tablet compositions of dexlansoprazole

granted A61KA61K31/4439A61K47/26

Quick answer

US patent 8563035 (Oral tablet compositions of dexlansoprazole) held by Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4439, A61K47/26, A61K47/38, A61K9/28